戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 g was commenced to prevent thrombosis of the oxygenator.
2 uidic device with an integrated differential oxygenator.
3 le blood from human volunteers on a membrane oxygenator.
4 ent circuit and passed it through a membrane oxygenator.
5 usting the CO2 gas flow through the membrane oxygenator.
6  25% by placement on extracorporeal membrane oxygenator.
7 ention group received NO 20 ppm into the CPB oxygenator.
8 on system composed of a pump, reservoir, and oxygenator.
9                                   A membrane oxygenator (0.65 m) was inserted within the hemofiltrati
10 s of the PAS included a 0.9 m 2 surface area oxygenator and a lightweight, battery-powered axial flow
11 ic chamber mimicking a hollow fiber membrane oxygenator and validate the model against these observat
12 achine for long-term use by adding long-term oxygenators and a dialysis filter.
13  applied to low-shear devices, such as blood oxygenators and catheters, where emerging information su
14              The different types of membrane oxygenators and pumps did not significantly alter hemost
15  consisted of a centrifugal pump, a membrane oxygenator, and a heat exchanger.
16 m consisted of a blood reservoir, a membrane oxygenator, and a nonocclusive roller pump.
17 ediately proximal and distal to the membrane oxygenator at 5 mins, 1 hr, and 3 hrs after the start of
18    AVCO2R was implanted using a hollow-fiber oxygenator attached to 12 F and 14 F vascular cannulas t
19                                          The oxygenator blood flow (p <0.001) and the CO2 removal rat
20   We show that this electrocatalytic on site oxygenator can sustain high cell loadings (>60k cells/mm
21 ated using a bespoke extracorporeal membrane oxygenator circuit before return to the donor.
22 ent of a system that incorporates a pumpless oxygenator circuit connected to the fetus of a lamb via
23 perfusion (volumetric flow) rate, and tubing/oxygenator components.
24                                The prototype oxygenator, consisting of cross-wound silicone hollow fi
25 in the late 19th century, primitive pump and oxygenator designs were the forerunners of major work by
26 thers in roller pump design and by Gibbon in oxygenator development.
27 l heart disease, NO administered via the CPB oxygenator did not improve neurodevelopmental outcomes o
28 de delivered into the cardiopulmonary bypass oxygenator during heart surgery.
29       The use of the extracorporeal membrane oxygenator (ECMO) for postoperative cardiac patients has
30 n patients receiving extracorporeal membrane oxygenator (ECMO) support.
31 ntinuation relies on extracorporeal membrane oxygenator (ECMO).
32                   The flow from the membrane oxygenator either returned directly to the patient circu
33 nula site bleeding (6.4% vs 4.7%, p = 0.03), oxygenator failure (16.7 vs 13.4%, p = 0.03), and circui
34 ad a significantly higher number of membrane oxygenator failures, changes to their cannulation sites,
35 mboses and adherent hMSCs found on explanted oxygenator fibers.Conclusions: Endobronchial hMSC therap
36 re conducted using a multiple diffuser micro-oxygenator for up to 6 months with an oxygen flow of 30
37 e model of ARDS and ECMO can impair membrane oxygenator function and does not improve oxygenation.
38  spent more hours on extracorporeal membrane oxygenator; had significantly higher heparin-induced thr
39      Closed system circuits using a membrane oxygenator have partially met these requirements but hav
40 uction of arterial-line filters and membrane oxygenators, have led to a reduction of both microemboli
41 administered into the cardiopulmonary bypass oxygenator improves ventilator-free days (days alive and
42 olume and a new high-efficiency hollow-fiber oxygenator in a circuit with a check valve flow control
43 o the gas flow of the cardiopulmonary bypass oxygenator may reduce postoperative low cardiac output s
44           Nitric oxide (NO) added to the CPB oxygenator may reduce systemic inflammation due to CPB a
45                                  We added an oxygenator module to our modular FABRICA bioreactor in o
46 pm delivered into the cardiopulmonary bypass oxygenator (n = 679) or standard care cardiopulmonary by
47 e is no uptake of morphine onto the membrane oxygenator of the ECMO circuit.
48 t in the extracorporeal membrane oxygenation oxygenators of patients with pneumonia, especially in th
49 onor blood, and ex vivo circuitry tubing and oxygenators) of the Organ Care System (OC) (TransMedics,
50 ociated deep vein thrombosis, and two had an oxygenator or pump thrombosis.
51 ted thrombosis among extracorporeal membrane oxygenator patients at our institution is relatively hig
52 d high-risk group of extracorporeal membrane oxygenator patients may be needed.
53           Ninety-six extracorporeal membrane oxygenator patients met the inclusion criteria.
54 prospectively on all extracorporeal membrane oxygenator patients.
55  optimal strategy in extracorporeal membrane oxygenator patients.
56 ed for 2 hours in an extracorporeal membrane oxygenator perfusion circuit at 37 degrees C.
57 had a significant elevation in transmembrane oxygenator pressure gradients.
58 bolic event while on extracorporeal membrane oxygenator (prevalence of heparin-induced thrombocytopen
59 cuit was established by using a hollow fiber oxygenator, primed with maternal sheep blood (150-200 mL
60                                          The oxygenator resistance remained consistent without signif
61           Pump performance, oxygen transfer, oxygenator resistance, and hematologic parameters were m
62         On an average of both positions, the oxygenator's blood flow was 410 +/- 30 mL/min and the CO
63 derwent venoarterial extracorporeal membrane oxygenator; spent more hours on extracorporeal membrane
64 d dog hindlimb perfused with a pump-membrane oxygenator system, the oxygen delivery (DO(2)) was lower
65 was injected just downstream of the membrane oxygenator; the lithium ion concentration-time curves we
66 clusion of the centrifugal pump, and one had oxygenator thrombosis requiring circuit replacement.
67 ngle-piston, nonporous hollow silicone fiber oxygenator to adequately support gas exchange, allowing
68                   Oxygen was attached to the oxygenator to provide the sweep gas.
69 nd in the flow just upstream of the membrane oxygenator using lithium selective electrodes.
70 te (p = 0.083) were higher when the membrane oxygenator was placed upstream of the hemofilter.
71                       Oxygen delivery by the oxygenator was significantly increased at Fio2 of 0.10,